Business Description
Sinopharm Group Co Ltd
NAICS : 325412
ISIN : CNE100000FN7
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.87 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 0.99 | |||||
Debt-to-EBITDA | 6.24 | |||||
Interest Coverage | 7.34 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.57 | |||||
Beneish M-Score | -2.76 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.5 | |||||
3-Year EBITDA Growth Rate | 7.3 | |||||
3-Year EPS without NRI Growth Rate | 7.2 | |||||
3-Year FCF Growth Rate | 3 | |||||
3-Year Book Growth Rate | 11.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 2.67 | |||||
Future 3-5Y Total Revenue Growth Rate | 10.68 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 74.71 | |||||
9-Day RSI | 67.69 | |||||
14-Day RSI | 61.25 | |||||
6-1 Month Momentum % | 2.99 | |||||
12-1 Month Momentum % | -27.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.39 | |||||
Quick Ratio | 1.15 | |||||
Cash Ratio | 0.26 | |||||
Days Sales Outstanding | 234.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 4.18 | |||||
Dividend Payout Ratio | 0.24 | |||||
3-Year Dividend Growth Rate | 8.1 | |||||
Forward Dividend Yield % | 4.37 | |||||
5-Year Yield-on-Cost % | 5.97 | |||||
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | 11.59 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 4.17 | |||||
Net Margin % | 1.61 | |||||
ROE % | 6.57 | |||||
ROA % | 1.2 | |||||
ROIC % | 5.05 | |||||
ROC (Joel Greenblatt) % | 12.51 | |||||
ROCE % | 8.64 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 7.03 | |||||
Forward PE Ratio | 6.56 | |||||
PE Ratio without NRI | 5.74 | |||||
Shiller PE Ratio | 9.33 | |||||
Price-to-Owner-Earnings | 7.4 | |||||
PEG Ratio | 0.54 | |||||
PS Ratio | 0.21 | |||||
PB Ratio | 0.83 | |||||
Price-to-Tangible-Book | 0.95 | |||||
Price-to-Operating-Cash-Flow | 2.89 | |||||
EV-to-EBIT | 6.08 | |||||
EV-to-Forward-EBIT | 3.22 | |||||
EV-to-EBITDA | 6.08 | |||||
EV-to-Forward-EBITDA | 2.91 | |||||
EV-to-Revenue | 0.25 | |||||
EV-to-Forward-Revenue | 0.11 | |||||
EV-to-FCF | 3.8 | |||||
Price-to-Projected-FCF | 0.33 | |||||
Price-to-DCF (Earnings Based) | 0.24 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.54 | |||||
Price-to-Graham-Number | 0.49 | |||||
Price-to-Net-Current-Asset-Value | 2.19 | |||||
Earnings Yield (Greenblatt) % | 16.45 | |||||
Forward Rate of Return (Yacktman) % | 25.65 |